Folate Supplementation in Schizophrenia

NCT00249288 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Folate
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]